Playback speed
10 seconds
ESMO 2024 Insights: Rucaparib +/- Nivo as Maintenance in Newly Diagnosed Ovarian Cancer - ATHENA-COMBO Ph3 Trial
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Bradley J. Monk
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Bradley J. Monk
153 views
September 19, 2024
Login to view comments.
Click here to Login